Samir Bouayad-Gervais

Sam was born in Montréal where he first joined the Lubell group at the University of Montreal to work on peptide mimics. He then joined the Tyers group at the Institute for research in immunology and Cancer (IRIC) where he worked on macrocyclic inhibitors. In July 2016 he joined the Schoenebeck group for his PhD.